The authors of the article carried out a retrospective analysis of the case histories of 43 patients (age from 20 to 66 years) with chronic pelvic injuries, hospitalized in 2010-2019. The damage type was assessed according to the AO classification. At the previous stages of treatment, conservative stabilization of the pelvis was used - 12 (27.
View Article and Find Full Text PDFObjective: The aim: To conduct a thorough analysis of the surgical approach features in femoral head fractures combined with acetabulum posterior wall fractures; to analyze these patients' treatment results 12-36 months after the surgery; to determine the criteria affecting the satisfactory treatment results achievement in these injuries.
Patients And Methods: Materials and methods: The surgical treatment results were evaluated 13 and 36 months after the surgery. The retrospective analysis included 21 patients (17 men and 4 women) with femoral head fractures combined with the acetabulum posterior wall fractures.
Objective: The aim: To analyse the results of the delayed acetabulum posterior wall fractures treatment and to identify the negative factors affecting the outcome.
Patients And Methods: Materials and methods: The patients' treatment results have been assessed in 5 years after the surgery. The surgery was performed in 21 to 120 days after the injury, 44±11 days on average.
Objective: The aim: To analyse long-term results of treating patients with open fractures of low-leg bones within a specific time period and to describe concomitant problems.
Patients And Methods: Materials and methods: A retrospective study was carried out to evaluate the results of the final treatment of patients after one year and after five years. Patients were divided into two groups.
Background: The aim was to evaluate the analgesic efficacy and safety of the dexketoprofen/tramadol 25 mg/75 mg fixed-dose combination vs dexketoprofen (25 mg) and tramadol (100 mg) in moderate-to-severe acute pain after total hip arthroplasty.
Methods: This was a randomized, double-blind, parallel-group study in patients experiencing pain of at least moderate intensity on the day after surgery, compared with placebo at first administration to validate the pain model. The study drug was administered orally every 8 h throughout a 5 day period.